Advanced Biomed Inc. terminated a $25,000,000 common stock purchase agreement with Helena Global Investment Opportunities I Ltd. effective July 21, 2026. The company had not issued any shares under the agreement other than commitment fee shares. Advanced Biomed Inc. operates in the biotechnology/biomedical industry and develops biomedical products.

Advanced Biomed Inc. entered into a Share Purchase Agreement on June 30, 2026, to sell 100% of its wholly-owned Taiwan Subsidiary, which manages its biomedical research and development operations, for $490,000. The transaction is expected to close within three months. Following the sale, the company will focus on its AI-focused operations through Acellent Technologies (Hong Kong) Co. Limited. Advanced Biomed Inc. operates in the biomedical and AI technology sectors.